![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
H Matthes, U Boschert, N Amlaiky, R Grailhe, JL Plassat, F Muscatelli, MG Mattei and R Hen
Laboratoire de Genetique Moleculaire des Eucaryotes du CNRS, U/184 de l'INSERM, Departement de Neurobiologie, Faculte de Medecine, Strasbourg, France.
Serotonin [5-hydroxytryptamine (5-HT)] is a neuromodulator that mediates a wide range of physiological functions by activating multiple receptors. Using a strategy based on amino acid sequence homology between 5-HT receptors that interact with guanine nucleotide-binding proteins, we have isolated from a mouse brain library a cDNA encoding a new serotonin receptor. Amino acid sequence comparisons revealed that this receptor was a close relative of the previously identified 5-HT5 receptor but was distant from all other 5-HT receptor subtypes; we therefore named it 5-HT5B. When expressed in COS-7 cells, the 5-HT5B receptor displayed a high affinity for the serotonergic radioligand 125I-lysergic acid diethylamide. Its pharmacological profile was distinct from that of all classic 5-HT receptor subtypes. However, the high affinity of the 5-HT5B receptor for 5-carboxamidotryptamine and its low affinity for sumatriptan indicated that it might correspond to recently described 5-HT1D-like binding sites that were labeled with [3H]5-carboxamidotryptamine and insensitive to sumatriptan. In situ hybridization experiments revealed that the 5-HT5B mRNA was expressed predominantly in the habenula and in the CA1 field of the hippocampus. We also determined the chromosomal localization of the 5-HT5A and 5- HT5B genes and of their human counterparts. The 5-HT5A gene colocalized with the mouse mutation reeler and the human mutation holoprosencephaly type 3, which both result in abnormal brain development, raising the possibility that the 5-HT5A receptor plays a role in brain development.
This article has been cited by other articles:
|
|
 |
|
  T. R. Dreszer, G. D. Wall, D. Haussler, and K. S. Pollard Biased clustered substitutions in the human genome: The footprints of male-driven biased gene conversion Genome Res., October 1, 2007; 17(10): 1420 - 1430. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Bayer, T. Muller, D. Myrtek, S. Sorichter, M. Ziegenhagen, J. Norgauer, G. Zissel, and M. Idzko Serotoninergic Receptors on Human Airway Epithelial Cells Am. J. Respir. Cell Mol. Biol., January 1, 2007; 36(1): 85 - 93. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Idzko, E. Panther, C. Stratz, T. Muller, H. Bayer, G. Zissel, T. Durk, S. Sorichter, F. Di Virgilio, M. Geissler, et al. The Serotoninergic Receptors of Human Dendritic Cells: Identification and Coupling to Cytokine Release J. Immunol., May 15, 2004; 172(10): 6011 - 6019. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. B. Francken, K. Josson, P. Lijnen, M. Jurzak, W. H. M. L. Luyten, and J. E. Leysen Human 5-Hydroxytryptamine5A Receptors Activate Coexpressed Gi and Go Proteins in Spodoptera frugiperda 9 Cells Mol. Pharmacol., May 1, 2000; 57(5): 1034 - 1044. [Abstract] [Full Text]
|
|
|
|
 |
|
 G. Pineyro and P. Blier Autoregulation of Serotonin Neurons: Role in Antidepressant Drug Action Pharmacol. Rev., September 1, 1999; 51(3): 533 - 591. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Delay, S. C. Kinnamon, and S. D. Roper Serotonin Modulates Voltage-Dependent Calcium Current in Necturus Taste Cells J Neurophysiol, May 1, 1997; 77(5): 2515 - 2524. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Moret and M. Briley The unique effect of methiothepin on the terminal serotonin autoreceptor in the rat hypothalamus could be an example of inverse agonism J Psychopharmacol, January 1, 1993; 7(4): 331 - 337. [Abstract] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
